Wells Fargo & Company I Teos Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 14,242 shares of ITOS stock, worth $116,641. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,242

Previous 11,431 24.59%

Holding current value

$116,641

Previous $169,000 14.2%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.09 - $17.97 $28,362 - $50,513	2,811 Added 24.59%	14,242 $145,000
Q2 2024 Aug 13, 2024	BUY	$10.33 - $18.09 $14,462 - $25,326	1,400 Added 13.96%	11,431 $169,000
Q1 2024 May 10, 2024	BUY	$9.89 - $13.64 $23,320 - $32,163	2,358 Added 30.73%	10,031 $136,000
Q4 2023 Feb 09, 2024	SELL	$8.57 - $11.06 $119,465 - $154,176	-13,940 Reduced 64.5%	7,673 $84,000
Q3 2023 Nov 13, 2023	SELL	$10.95 - $14.6 $41,040 - $54,720	-3,748 Reduced 14.78%	21,613 $236,000
Q2 2023 Aug 15, 2023	BUY	$12.93 - $18.05 $10,253 - $14,313	793 Added 3.23%	25,361 $335,000
Q1 2023 May 12, 2023	BUY	$13.02 - $22.62 $310,592 - $539,600	23,855 Added 3345.72%	24,568 $334,000
Q4 2022 Feb 13, 2023	SELL	$17.77 - $21.6 $26,850 - $32,637	-1,511 Reduced 67.94%	713 $13,000
Q3 2022 Nov 14, 2022	SELL	$18.6 - $27.25 $4,110 - $6,022	-221 Reduced 9.04%	2,224 $42,000
Q2 2022 Aug 12, 2022	SELL	$16.57 - $35.1 $5,915 - $12,530	-357 Reduced 12.74%	2,445 $51,000
Q1 2022 May 16, 2022	SELL	$31.92 - $47.45 $177,315 - $263,584	-5,555 Reduced 66.47%	2,802 $89,000
Q4 2021 Feb 14, 2022	SELL	$26.23 - $47.86 $1.35 Million - $2.47 Million	-51,544 Reduced 86.05%	8,357 $390,000
Q3 2021 Nov 15, 2021	BUY	$23.91 - $29.58 $1.43 Million - $1.77 Million	59,685 Added 27631.94%	59,901 $1.62 Million
Q2 2021 Aug 16, 2021	SELL	$17.9 - $36.1 $29,678 - $59,853	-1,658 Reduced 88.47%	216 $5,000
Q1 2021 May 13, 2021	SELL	$30.86 - $44.2 $183,215 - $262,415	-5,937 Reduced 76.01%	1,874 $64,000
Q4 2020 Feb 09, 2021	SELL	$21.59 - $33.95 $1,986 - $3,123	-92 Reduced 1.16%	7,811 $264,000
Q3 2020 Nov 05, 2020	BUY	$17.57 - $32.92 $138,855 - $260,166	7,903 New	7,903 $195,000

Others Institutions Holding ITOS

# of Institutions

166

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $291M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company I Teos Therapeutics, Inc. Transaction History